DYSLIPIDEMIAS

This study tested a single pill containing three medicines (telmisartan, amlodipine, and rosuvastatin) in 252 Korean adults with both high blood pressure and high cholesterol. After 8 weeks, the pill safely lowered both blood pressure and LDL (bad) cholesterol. People with very h…

This study tested whether a plant-based extract rich in phytosterols could improve cholesterol levels in 42 adults with high cholesterol. Participants took the extract or a placebo for a period, and researchers measured changes in their blood lipids. The goal was to see if this n…

This study tested a drug called Cipros 20 in 406 adults with dyslipidemia (abnormal blood fats) and high heart disease risk. The goal was to see if it lowers triglycerides and LDL cholesterol more effectively than a placebo. Participants took the medication and had their blood fa…

This phase 3 study tested a daily pill that combines two drugs, obicetrapib and ezetimibe, in 407 adults with inherited high cholesterol or heart disease who were already on maximum cholesterol-lowering therapy. The goal was to see if the combination could further lower LDL (bad)…

This study looked at whether a three-month supervised exercise program can help men with type 2 diabetes, prediabetes, or obesity improve their blood sugar, body composition, and fitness. Three hundred sedentary men aged 35-65 took part in regular training sessions at a fitness c…

This study looked at whether taking fish oil supplements while exercising can lower inflammation linked to obesity. 129 overweight or obese adults with high triglycerides and prediabetes took part. Researchers measured changes in blood markers of inflammation, cholesterol, blood …

This study tested a new drug called obicetrapib in over 2,500 adults with high cholesterol or heart disease whose cholesterol was not well-controlled by their current medications. Participants took either the drug or a placebo pill daily for about 6 months. The main goal was to s…

This early-stage study tested a new drug called ARO-ANG3 in 93 healthy adults and patients with high cholesterol or high triglycerides. The main goal was to check safety and how the drug moves through the body. Researchers gave single or multiple doses to see if it could help con…

This study looked at the long-term safety of a drug called ARO-APOC3 in 418 adults with dyslipidemia (abnormal fat levels in the blood). Participants who completed a previous 12-month study received the drug every 3 or 6 months. The main goal was to track side effects, and the st…

This study tested whether a personalized lifestyle program could help adults with insulin resistance, obesity, diabetes, or related conditions improve their metabolic health. Forty participants first received either nutrition or exercise counseling. Those who didn't improve after…

This study tested a digital quality improvement program to help people with heart disease lower their LDL (bad) cholesterol. Over 1,400 patients in Brazil used a smartphone-based tool to improve cholesterol management. The goal was to see if this approach helps doctors and patien…

This study tested a new extended-release tablet called K-877 in 121 adults with high triglycerides (a type of blood fat). Participants took the drug once daily for 52 weeks, starting at a low dose and increasing if needed. The goal was to see if the drug safely lowers triglycerid…

This study tested a new controlled-release version of the drug pemafibrate in 60 adults with dyslipidemia (abnormal fat levels in the blood). The goal was to see if the new tablet works better than the current version at lowering triglycerides and improving cholesterol. Participa…

This study looked at whether drinking Dachundou No Sugar Added Soymilk every day for 8 weeks could help lower cholesterol in adults with high cholesterol. 25 people with total cholesterol of 200 mg/dL or higher took part. Researchers measured cholesterol, blood pressure, and othe…

This study looked at how eating different amounts of pecans each day for 28 days affects heart health in 108 adults who are overweight or have high cholesterol. Participants ate pecans as part of their diet or stuck to their usual eating habits. Researchers measured changes in bl…

This study tested a drug called alirocumab in 118 people with HIV who were at risk for heart disease. The drug aims to lower cholesterol and reduce inflammation in the arteries, which can lead to heart attacks. Participants received either the drug or a placebo for about a year, …

This study looked at whether a low dose (10 mg) of the statin drug rosuvastatin can effectively lower LDL cholesterol in Korean adults who need cholesterol-lowering therapy. Researchers enrolled 242 participants with different risk levels, including those with heart disease, very…

This study looked at whether taking phytosterols (natural plant compounds) for 3 months could improve liver health, cholesterol, and insulin levels in 27 adults with nonalcoholic fatty liver disease (NAFLD). Participants took daily supplements while researchers tracked changes in…

This study tested a new way to help staff at mental health programs provide better care for heart health risks like diabetes, high blood pressure, and high cholesterol. 85 staff and people with serious mental illness took part. The goal was to see if the program improved how staf…

This study looked at how different amounts of cottonseed oil affect cholesterol, blood sugar, and other health markers in 95 adults at risk for heart disease. Participants drank shakes and ate snacks with cottonseed oil daily for 28 days. Researchers compared low, medium, and hig…

This study looked at how taking statins (a common cholesterol-lowering drug) along with regular exercise affects muscle cells and overall fitness in adults aged 40-65 with high cholesterol. About 120 participants were split into four groups: exercise plus placebo, exercise plus s…

This early-phase study tested a single dose of VSA003 in 36 healthy Chinese adults with mildly high cholesterol or triglycerides. The main goal was to check safety and how the drug moves through the body, not to treat the condition. Participants were monitored for side effects an…

This early-stage study tested the safety and how the body processes a new drug called Atorvo+™ in 24 healthy adults aged 40 to 75. The main goal was to check for side effects and measure drug levels in the blood. Since it was a Phase 1 trial in healthy people, it did not aim to t…